FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226375899> ?p ?o ?g. }

• W4226375899 endingPage "453" @default.
• W4226375899 startingPage "439" @default.
• W4226375899 abstract "To evaluate the optimal dosing regimens of meropenem against extended-spectrum beta-lactamase-producing Escherichia coli (ESBL E. coli) in critically ill patients with varying degrees of renal function using Monte Carlo simulation (MCS).The MCS was performed using the minimum inhibitory concentration (MIC) data from Right Laboratory and Health Screen in Naypyitaw, Myanmar, as well as reported meropenem pharmacokinetic parameters in the target population and the pharmacokinetic-pharmacodynamic index. For each dosing regimen, 10,000 virtual patients were generated to assess the probability of target attainment (PTA) and the cumulative fraction of response (CFR). The most effective dosage regimens were determined using PTA and a CFR of 90%.ESBL E. coli made up 93 of the 396 clinical E. coli isolates, and they are all multidrug-resistant, with resistance to at least five antibiotic classes. The MIC50 and MIC90 were determined to be 0.25 μg/mL. The PTA was affected by five factors: creatinine clearance (CLcr), vasopressor usage, MIC, infusion time, and dosage fractionation. In patients who did not receive vasopressors, the current regimens (US-FDA and EMA) were ineffective in all renal function for MIC >0.25μg/mL. In the subset group of CLcr >80 mL/min for MIC 2μg/mL, the maximum total daily dose of 6g/day (2g q 8hr; 3hr infusion) was still ineffective, but 4g/day (1g q 6hr; 3hr infusion) achieved 98.96% PTA. Almost majority of the simulated regimens produced >90% PTA in vasopressor-dependent patients with all levels of renal function, resulting in a decreased total daily dose requirement.For high MIC (>1μg/mL) patients who do not use vasopressors and have a CLcr >80 mL/min, a combination of dosage fractionation and the extended infusion was considered as an effective technique to maximize target attainment. Neither prolonged infusion nor dosage fractionation should be explored in patients using vasopressors." @default.
• W4226375899 created "2022-05-05" @default.
• W4226375899 creator A5020853246 @default.
• W4226375899 creator A5029395411 @default.
• W4226375899 creator A5056580181 @default.
• W4226375899 creator A5064881775 @default.
• W4226375899 creator A5077860090 @default.
• W4226375899 date "2022-02-01" @default.
• W4226375899 modified "2023-09-26" @default.
• W4226375899 title "The Evaluation of Meropenem Dosing Regimens Against ESBL-Producing Escherichia coli in ICU Patients Using Monte Carlo Simulation" @default.
• W4226375899 cites W1536584715 @default.
• W4226375899 cites W1985630511 @default.
• W4226375899 cites W2064722076 @default.
• W4226375899 cites W2077149037 @default.
• W4226375899 cites W2096350581 @default.
• W4226375899 cites W2115215601 @default.
• W4226375899 cites W2131370687 @default.
• W4226375899 cites W2131946678 @default.
• W4226375899 cites W2136510570 @default.
• W4226375899 cites W2154007902 @default.
• W4226375899 cites W2165839757 @default.
• W4226375899 cites W2290106633 @default.
• W4226375899 cites W2340383377 @default.
• W4226375899 cites W2345473542 @default.
• W4226375899 cites W2501597565 @default.
• W4226375899 cites W2598891243 @default.
• W4226375899 cites W2753460377 @default.
• W4226375899 cites W2779019546 @default.
• W4226375899 cites W2794430117 @default.
• W4226375899 cites W2808694326 @default.
• W4226375899 cites W2891168116 @default.
• W4226375899 cites W2929478224 @default.
• W4226375899 cites W2949083889 @default.
• W4226375899 cites W2963083740 @default.
• W4226375899 doi "https://doi.org/10.2147/idr.s345385" @default.
• W4226375899 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35177911" @default.
• W4226375899 hasPublicationYear "2022" @default.
• W4226375899 type Work @default.
• W4226375899 citedByCount "2" @default.
• W4226375899 countsByYear W42263758992022 @default.
• W4226375899 countsByYear W42263758992023 @default.
• W4226375899 crossrefType "journal-article" @default.
• W4226375899 hasAuthorship W4226375899A5020853246 @default.
• W4226375899 hasAuthorship W4226375899A5029395411 @default.
• W4226375899 hasAuthorship W4226375899A5056580181 @default.
• W4226375899 hasAuthorship W4226375899A5064881775 @default.
• W4226375899 hasAuthorship W4226375899A5077860090 @default.
• W4226375899 hasBestOaLocation W42263758991 @default.
• W4226375899 hasConcept C111113717 @default.
• W4226375899 hasConcept C112705442 @default.
• W4226375899 hasConcept C126322002 @default.
• W4226375899 hasConcept C126894567 @default.
• W4226375899 hasConcept C159641895 @default.
• W4226375899 hasConcept C176947019 @default.
• W4226375899 hasConcept C2777288759 @default.
• W4226375899 hasConcept C2779375183 @default.
• W4226375899 hasConcept C2908647359 @default.
• W4226375899 hasConcept C501593827 @default.
• W4226375899 hasConcept C71924100 @default.
• W4226375899 hasConcept C86803240 @default.
• W4226375899 hasConcept C89423630 @default.
• W4226375899 hasConcept C94665300 @default.
• W4226375899 hasConcept C98274493 @default.
• W4226375899 hasConcept C99454951 @default.
• W4226375899 hasConceptScore W4226375899C111113717 @default.
• W4226375899 hasConceptScore W4226375899C112705442 @default.
• W4226375899 hasConceptScore W4226375899C126322002 @default.
• W4226375899 hasConceptScore W4226375899C126894567 @default.
• W4226375899 hasConceptScore W4226375899C159641895 @default.
• W4226375899 hasConceptScore W4226375899C176947019 @default.
• W4226375899 hasConceptScore W4226375899C2777288759 @default.
• W4226375899 hasConceptScore W4226375899C2779375183 @default.
• W4226375899 hasConceptScore W4226375899C2908647359 @default.
• W4226375899 hasConceptScore W4226375899C501593827 @default.
• W4226375899 hasConceptScore W4226375899C71924100 @default.
• W4226375899 hasConceptScore W4226375899C86803240 @default.
• W4226375899 hasConceptScore W4226375899C89423630 @default.
• W4226375899 hasConceptScore W4226375899C94665300 @default.
• W4226375899 hasConceptScore W4226375899C98274493 @default.
• W4226375899 hasConceptScore W4226375899C99454951 @default.
• W4226375899 hasLocation W42263758991 @default.
• W4226375899 hasLocation W42263758992 @default.
• W4226375899 hasLocation W42263758993 @default.
• W4226375899 hasLocation W42263758994 @default.
• W4226375899 hasOpenAccess W4226375899 @default.
• W4226375899 hasPrimaryLocation W42263758991 @default.
• W4226375899 hasRelatedWork W18383156 @default.
• W4226375899 hasRelatedWork W1982353979 @default.
• W4226375899 hasRelatedWork W2076110457 @default.
• W4226375899 hasRelatedWork W2159751361 @default.
• W4226375899 hasRelatedWork W2291588333 @default.
• W4226375899 hasRelatedWork W2334636755 @default.
• W4226375899 hasRelatedWork W2415095571 @default.
• W4226375899 hasRelatedWork W2728973490 @default.
• W4226375899 hasRelatedWork W3021369409 @default.
• W4226375899 hasRelatedWork W4289315365 @default.
• W4226375899 hasVolume "Volume 15" @default.
• W4226375899 isParatext "false" @default.

• next